Variants in the NR3C1 gene have been reported in patients with MDD and obesity and found to confer reduced risk for quantitative metabolic traits and T2D in Cushing syndrome; variants have not been reported in T2D and MDD-T2D comorbid patients. The gene discussed is NR3C1; the disease is obesity due to melanocortin 4 receptor deficiency.